Abstract
Investigation and quantification of the relationship between the skin dose-volume histogram (DVH) and the risk of acute skin toxicity in breast cancer patients undergoing Tomotherapy by regression modeling. This prospective study included 52 breast cancer patients treated with Tomotherapy in the dose range of 42.5–60 Gy to the planned target volume. Grading of acute skin toxicity in patients was assessed by the maximum score recorded in weekly follow-ups during and up to three months’ post-radiation therapy using the Common Terminology Criteria for Adverse Events (CTCAE) v4.0 guidelines. A superficial layer with a thickness of 2 mm was designated as the Skin Representative Layer (SRL-2) on the Tomotherapy planning, and DVH was extracted for that. Then, multivariable and univariable logistic analyses were performed to identify the most predictive variables of acute skin toxicity from SRL-2 DVH values and patients’ clinical parameters. The regression analysis identified V51Gy, representing the absolute SRL-2 volume receiving 51 Gy or more in physical dose, as the most predictive dosimetric parameter for grade 2–3 acute skin toxicity. The optimal cut-off value was 4.74 cc for the physical dose, with an Area Under the Receiver Operating Characteristic (ROC) Curve (AUC) value of 0.749, even when adjusted for clinical and treatment-related variables. The logistic model based on V51Gy demonstrated superior calibration, with a slope and R² value approaching 1, indicating better agreement between predicted and observed outcomes. The risk of acute skin toxicity during breast cancer Tomotherapy is correlated with the V51Gy parameter of skin DVH. Limiting V51Gy < 4.74 cc, or 23.7 cm2 of skin area, should keep the risk of grade 2–3 acute skin toxicity below 26%.
figure 1
Axial, sagittal, and coronal views of the PTV and skin representative layer 2 mm contours in red and blue segments, respectively.
Full size image
figure 2
(a) Average skin DVHs comparing the G3/G2 group (grade 2–3 acute skin toxicity) with the G1/G0 group (grade 0–1 acute skin toxicity); and (b) two-tailed t-test P-values showing the differences between the DVHs of physical dose distribution in the studied patients.
Full size image
figure 3
Receiver operating characteristic curve for V51Gy of physical dose.
Full size image
figure 4
V51Gy logistic regression fitting.
Full size image
figure 5
The calibration plot of the logistic model of V51Gy.
Full size image